Sun Pharma in collaboration with the International Centre for Genetic engineering and Biotechnology (ICGEB), New Delhi will develop botanical drug for dengue.
Sun Pharma will develop Cipa, scientifically called Cissampelos Pareira, by following a drug registration process similar to that for a new chemical entity, consisting of all required in vitro, in vivo, pre-clinical and clinical studies meeting regulatory standards in India and worldwide, a joint statement issued by Sun Pharma and ICGEB said.
Founded in 1983, ICGEB is an international nonprofit research organization.
Sun Pharma with ICGEB to develop dengue cure medicine pic.twitter.com/lZCFy4L7ta— Press Release Watch (@PrReleaseWatch) May 4, 2016
Sun Pharma will develop Cipa, scientifically called Cissampelos Pareira, by following a drug registration process similar to that for a new chemical entity, consisting of all required in vitro, in vivo, pre-clinical and clinical studies meeting regulatory standards in India and worldwide, a joint statement issued by Sun Pharma and ICGEB said.
Founded in 1983, ICGEB is an international nonprofit research organization.
